L, B., BS, H., E, H., B, S., AF, S., M, T., & T, R. (2024). Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply. Alimentary pharmacology & therapeutics, 60(1), 107. https://doi.org/10.1111/apt.18067
Chicago Style (17th ed.) CitationL, Burghart, Hofer BS, Halilbasic E, Simbrunner B, Staettermayer AF, Trauner M, and Reiberger T. "Letter: Fibrates May Be Safe and Effective in Patients with Primary Biliary Cholangitis and Decompensated Cirrhosis-Authors' Reply." Alimentary Pharmacology & Therapeutics 60, no. 1 (2024): 107. https://doi.org/10.1111/apt.18067.
MLA (9th ed.) CitationL, Burghart, et al. "Letter: Fibrates May Be Safe and Effective in Patients with Primary Biliary Cholangitis and Decompensated Cirrhosis-Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 60, no. 1, 2024, p. 107, https://doi.org/10.1111/apt.18067.